NCT01472250View on ClinicalTrials.gov

A Prospective and Observational Cohort Study to Evaluate the Treatment Model and Medical Economics of Advanced Gastric Cancer Chemotherapy in Clinical Practice in China

CompletedOBSERVATIONAL
Enrollment

498

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Advanced Gastric Cancer
Interventions
DRUG

Clinical chemo-drugs

"Clinical drugs will be selected by the investigator according to recommendations in Chinese and foreign guidelines and depending on clinical experience and the patient's individual conditions, including but not limited to the drugs listed below:~Platinum products: oxaliplatin, cisplatin Fluorouracil products: 5-fluorouracil, capecitabine, TS-1 Taxanes: paclitaxel, docetaxel"

Trial Locations (1)

100142

Lin Shen, Beijing

All Listed Sponsors
lead

Peking University

OTHER

NCT01472250 - A Prospective and Observational Cohort Study to Evaluate the Treatment Model and Medical Economics of Advanced Gastric Cancer Chemotherapy in Clinical Practice in China | Biotech Hunter | Biotech Hunter